ACTIVE

AstraZeneca

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

8,6 M €

+5.6% YoY

Revenue

351,2 M €

+10.6% YoY

Equity

46,9 M €

+22.6% YoY

Workforce

234,4 ETP

+5.7% YoY

What does AstraZeneca do?

AstraZeneca is a Public limited company incorporated in 1948. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Dilbeek. It employs on average 234,4 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0400.165.679

Incorporation

28/11/1948

Legal form

Public limited company

Registered office

Alfons Gossetlaan 40 box 201
1702 Dilbeek · FlandreSee on map

Contributed capital

26 583 725,34 €

Latest accounts

31/12/2025

Average workforce

234,4 ETP

Activities (NACE)

46460Wholesale of pharmaceutical goods· main 46460Wholesale of pharmaceutical goods 51460Air transport

Joint committees (2)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debtsHigh revenue

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 19 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007
Income statement
Revenue	351,2 M €	+10.6%	317,5 M €	+13.9%	278,7 M €	+23.2%	226,1 M €	+31.3%	172,2 M €	+6.5%	161,7 M €	+17.2%	138 M €	+18.0%	116,9 M €	-25.0%	155,9 M €	-8.0%	169,5 M €	-3.1%	174,9 M €	-10.0%	194,4 M €	-2.8%	199,9 M €	-12.0%	227,3 M €	-8.0%	247,2 M €	-0.8%	249,1 M €	-49.8%	496,3 M €	+7.5%	461,8 M €	+2.1%	452,5 M €
EBITDA	12,1 M €	+36.9%	8,9 M €	-15.1%	10,4 M €	+38.5%	7,5 M €	+37.4%	5,5 M €	+17.3%	4,7 M €	-11.9%	5,3 M €	-9.8%	5,9 M €	+42.2%	4,1 M €	-27.0%	5,7 M €	+84.3%	3,1 M €	-67.2%	9,4 M €	-4.9%	9,9 M €	-22.1%	12,6 M €	-38.2%	20,4 M €	-6.5%	21,9 M €	-30.6%	31,5 M €	+53.2%	20,6 M €	-19.6%	25,6 M €
Operating result	12 M €	+35.6%	8,8 M €	-14.1%	10,3 M €	+37.6%	7,5 M €	+27.9%	5,8 M €	+29.3%	4,5 M €	-12.1%	5,1 M €	-10.8%	5,8 M €	+54.2%	3,7 M €	-31.0%	5,4 M €	+104%	2,7 M €	-70.2%	8,9 M €	-5.3%	9,4 M €	-22.3%	12,1 M €	-40.0%	20,2 M €	-6.1%	21,5 M €	-28.9%	30,2 M €	+58.1%	19,1 M €	-22.5%	24,7 M €
Net result	8,6 M €	+5.6%	8,2 M €	-10.1%	9,1 M €	+75.0%	5,2 M €	+33.8%	3,9 M €	+29.9%	3 M €	-2.6%	3,1 M €	-19.4%	3,8 M €	+90.9%	2 M €	-36.5%	3,1 M €	+78.7%	1,8 M €	-73.7%	6,7 M €	+250%	-4,5 M €	-184%	5,3 M €	+171%	1,9 M €	-89.8%	19 M €	+12.4%	16,9 M €	+495%	2,8 M €	-81.7%	15,6 M €
Balance sheet
Equity	46,9 M €	+22.6%	38,2 M €	-39.4%	63 M €	+16.9%	53,9 M €	+10.7%	48,7 M €	+8.7%	44,8 M €	+7.2%	41,8 M €	+7.9%	38,8 M €	+10.9%	35 M €	+6.1%	33 M €	-2.5%	33,8 M €	+5.5%	32,1 M €	+26.3%	25,4 M €	-27.2%	34,8 M €	+10.4%	31,6 M €	-35.1%	48,6 M €	+4.3%	46,6 M €	-17.8%	56,7 M €	+5.3%	53,8 M €
Total assets	105,4 M €	+19.7%	88 M €	-6.5%	94,1 M €	-5.5%	99,6 M €	+10.0%	90,6 M €	+24.3%	72,8 M €	+16.7%	62,4 M €	-0.6%	62,8 M €	-2.3%	64,3 M €	+1.8%	63,1 M €	+2.1%	61,8 M €	-2.5%	63,4 M €	-5.4%	67 M €	-20.6%	84,4 M €	-30.3%	121,1 M €	+19.8%	101,1 M €	-15.7%	120 M €	-26.5%	163,2 M €	+36.9%	119,2 M €
Cash	1,5 M €	+96.1%	752,5 k €	-26.2%	1 M €	-19.0%	1,3 M €	+9.8%	1,1 M €	+16.8%	981,6 k €	-2.5%	1 M €	-74.2%	3,9 M €	+696%	489,1 k €	+7.7%	454,2 k €	+41.3%	321,5 k €	-34.4%	490,1 k €	-26.4%	665,5 k €	+56.3%	425,9 k €	-70.0%	1,4 M €	-83.9%	8,8 M €	-30.0%	12,6 M €	+17.8%	10,7 M €	+402%	2,1 M €
Debts	58,5 M €	+17.4%	49,8 M €	+60.3%	31,1 M €	-25.1%	41,5 M €	-0.6%	41,8 M €	+52.1%	27,5 M €	+36.5%	20,1 M €	-9.4%	22,2 M €	-19.5%	27,6 M €	-3.3%	28,5 M €	+13.3%	25,2 M €	-8.2%	27,4 M €	-5.6%	29 M €	-12.4%	33,2 M €	-11.5%	37,5 M €	-18.7%	46,1 M €	-11.0%	51,8 M €	-41.5%	88,5 M €	+39.9%	63,3 M €
Other
Workforce	234,4 ETP	+5.7%	221,7 ETP	+4.8%	211,5 ETP	+13.0%	187,2 ETP	+4.2%	179,6 ETP	+5.0%	171,0 ETP	+4.7%	163,3 ETP	-2.2%	166,9 ETP	-4.4%	174,5 ETP	-2.0%	178,1 ETP	-7.4%	192,3 ETP	-0.5%	193,3 ETP	-14.4%	225,9 ETP	-31.6%	330,2 ETP	-32.8%	491,2 ETP	+1.2%	485,2 ETP	-15.0%	570,5 ETP	+2.6%	556,3 ETP	-3.6%	577,3 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 50 M€ and 100 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 4 active · 44 ended

Active mandates

Angela Thompson

Managing director · since 25 février 2025 · until 26 mai 2028

Active

Jennifer Olivero

Director · since 19 mai 2022 · until 26 mai 2028

Active

Luca Taliercio

Director · since 19 mai 2022 · until 26 mai 2028

Active

Paul Van Mullem

Director · since 19 mai 2022 · until 26 mai 2028

Active

Ended mandates

Keira Driansky

Managing director · since 21 septembre 2022 · until 30 avril 2024

Ended

Keira Driansky

Managing director · since 21 septembre 2022 · until 26 mai 2028

Ended

Luca Taliercio

Director · since 01 janvier 2022 · until 27 mai 2022

Ended

Jennifer Olivero

Director · since 29 septembre 2021 · until 27 mai 2022

Ended

At this address

Other companies at this address

Company	CBE no.
Amplifon Belgium● Active	0418.975.266
Babel Music● Active	0413.046.586
CMP-LAW● Active	1017.596.019
CYCLE VALLEY● Active	0667.738.102
FOUNDATION AstraZeneca● Active	0452.299.023
Gus Foods● Active	0755.989.195
Intersong-Primavera, Editions Musicales● Active	0403.030.644
iwell Belgium● Active	1012.271.610
KarmaKarma● Active	0643.997.252
KatariComms● Active	0637.787.767
neeoo● Active	1042.011.315
neeoo Holding● Active	1042.008.642
WARNER CHAPPELL MUSIC BELGIUM● Active	0426.906.601
WARNER MUSIC BENELUX● Active	0417.118.905

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	17/06/2026	23/06/2025	17/07/2024	04/10/2023	24/06/2022	15/06/2021
General meeting	29/05/2026	30/05/2025	31/05/2024	26/05/2023	27/05/2022	28/05/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

21 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2025	29/05/2026	17/06/2026	Dutch	PDF
Full model	31/12/2024	30/05/2025	23/06/2025	Dutch	PDF
Full model	31/12/2023	31/05/2024	17/07/2024	Dutch	PDF
Full modelCorrection	31/12/2022	26/05/2023	04/10/2023	Dutch	PDF
Full model	31/12/2022	26/05/2023	21/06/2023	Dutch	PDF
Full model	31/12/2021	27/05/2022	24/06/2022	Dutch	PDF
Full model	31/12/2020	28/05/2021	15/06/2021	Dutch	PDF
Full model	31/12/2019	29/05/2020	31/07/2020	Dutch	PDF
Full model	31/12/2018	29/05/2019	11/07/2019	Dutch	PDF
Full model	31/12/2017	25/05/2018	05/06/2018	Dutch	PDF
Full model	31/12/2016	24/05/2017	26/06/2017	Dutch	PDF
Full model	31/12/2015	27/05/2016	06/06/2016	Dutch	PDF
Full model	31/12/2014	29/05/2015	09/06/2015	Dutch	PDF
Full model	31/12/2013	30/05/2014	17/06/2014	Dutch	PDF
Full model	31/12/2012	31/05/2013	24/06/2013	Dutch	PDF
Full model	31/12/2011	31/05/2012	25/06/2012	Dutch	PDF
Full model	31/12/2010	27/05/2011	17/06/2011	Dutch	PDF
Full model	31/12/2009	28/05/2010	29/06/2010	Dutch	PDF
Full model	31/12/2008	29/05/2009	26/06/2009	Dutch	PDF
Full model	31/12/2007	30/05/2008	24/06/2008	Dutch	PDF
Full model	31/12/2006	25/05/2007	22/06/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 50 M€ and 100 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 4 active · 44 ended

Active mandates

Angela Thompson

Managing director · since 25 février 2025 · until 26 mai 2028

Active

Jennifer Olivero

Director · since 19 mai 2022 · until 26 mai 2028

Active

Luca Taliercio

Director · since 19 mai 2022 · until 26 mai 2028

Active

Paul Van Mullem

Director · since 19 mai 2022 · until 26 mai 2028

Active

Ended mandates

Keira Driansky

Managing director · since 21 septembre 2022 · until 30 avril 2024

Ended

Keira Driansky

Managing director · since 21 septembre 2022 · until 26 mai 2028

Ended

Luca Taliercio

Director · since 01 janvier 2022 · until 27 mai 2022

Ended

Jennifer Olivero

Director · since 29 septembre 2021 · until 27 mai 2022

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates10/06/2026
ONTSLAGEN - BENOEMINGEN
PDF
Mandates04/04/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates05/08/2024
ONTSLAGEN - BENOEMINGEN
PDF
Mandates05/07/2023
ONTSLAGEN - BENOEMINGEN
PDF
Mandates13/10/2022
ONTSLAGEN - BENOEMINGEN
PDF
Mandates13/07/2022
ONTSLAGEN - BENOEMINGEN
PDF
Mandates07/04/2022
ONTSLAGEN - BENOEMINGEN
PDF
Other03/11/2021
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

29/05/2026
nominationKPMG Bedrijfsrevisoren BV/KPMG Réviseurs d'Entreprises SRL — commissaris
2025
Annual accounts 20258,6 M €↑
25/02/2025
nominationAngela Thompson — gedelegeerd bestuurder
21/02/2025
nominationAngela Thompson — bestuurder
2024
Annual accounts 20248,2 M €↓
2023
Annual accounts 20239,1 M €↑
26/05/2023
reconductionPwC Bedrijfsrevisoren BV — commissaris
26/05/2023
nominationRomain Seffer — vertegenwoordiger van de commissaris
2022
Annual accounts 20225,2 M €↑
21/09/2022
demissionKeira Driansky — bestuurder en als persoon belast met het dagelijks bestuur
21/09/2022
nominationKeira Driansky — bestuurder
19/05/2022
reconductionAnne-Laure Dréno — bestuurder
19/05/2022
reconductionJennifer Olivero — bestuurder
19/05/2022
reconductionLuca Taliercio — bestuurder
19/05/2022
reconductionPaul Van Mullem — bestuurder
2021
Annual accounts 20213,9 M €↑
2020
Annual accounts 20203 M €↓
2019
Annual accounts 20193,1 M €↓
2018
Annual accounts 20183,8 M €↑
2017
Annual accounts 20172 M €↓
2016
Annual accounts 20163,1 M €↑
2015
Annual accounts 20151,8 M €↓
2014
Annual accounts 20146,7 M €↑
2013
Annual accounts 2013-4,5 M €↓
2012
Annual accounts 20125,3 M €↑
2011
Annual accounts 20111,9 M €↓
2010
Annual accounts 201019 M €↑
2009
Annual accounts 200916,9 M €↑
2008
Annual accounts 20082,8 M €↓
2007
Annual accounts 200715,6 M €
28/11/1948
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

AstraZeneca

Overview

What does AstraZeneca do?

Trend over 19 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline